Free Republic

Even short-term use of some painkillers could be dangerous for people who've had a heart attack, according to research published in Circulation: Journal of the American Heart Association. Researchers analyzed the duration of prescription non-steroidal anti-inflammatory drugs (NSAIDs) treatment and cardiovascular risk in a nationwide Danish cohort of patients with prior heart attack. They found the use of NSAIDs was associated with a 45 percent increased risk of death or recurrent heart attack within as little as one week of treatment, and a 55 percent increased risk if treatment extended to three months. The study was limited by its observational...

WASHINGTON -- The number of prescription drugs in short supply has more than tripled since 2005 and shortages are now more frequent than ever, [] Premier Healthcare Alliance -- a performance improvement alliance of more than 2,500 U.S. hospitals -- surveyed 311 pharmacy experts at hospitals and other facilities, such as surgery centers and long-term care facilities, about shortages during a six month period in 2010. The survey found that 89% had experienced shortages that may have caused a medication safety issue or error in patient care. Eight out of 10 times a shortage occurred, the patient's care was delayed...

An anonymous email making the cyberspace rounds is so upsetting that its author was correct to hide his name. The “Changes Are Coming” email details the demise of our post office, our newspapers, check writing systems, books and music as we know them along with the end of Cable TV and network systems as now constituted. But the harshest caveat bearing down on America is our demise due to deindustrialization. The email reports that “Tens of thousands of factories have left the U.S. in the past decade alone. Millions upon millions of manufacturing jobs have been lost. . .the U.S....

Dr. Theresa Deisher speaks at the HLI conference last weekend. WASHINGTON, D.C., December 8, 2010 (LifeSiteNews.com) - Every day in America, countless packages are carefully transferred for use by government, university, pharmaceutical and other biotechnology laboratories. Some of these end up advancing development of products such as cosmetics and food additives; others are used directly as a form of therapy. The material in those packages are human body parts - eyes, ears, limbs, brain, skin - now an indispensable commodity for many U.S. researchers and scientists, and a lucrative export of America’s abortion clinics. To see an example of an...

Publisher Peter Osnos, who admits to personally working with former Bush White House press secretary Scott McClellan on his new book, What Happened, began his career as an assistant to I.F. Stone, the pro-communist "journalist" named as a Soviet agent of influence who was the uncle of Weather Underground communist terrorist Kathy Boudin. But the connections don't end there. Boudin's son Chesa was raised by Barack Obama associates Bill Ayers and Bernardine Dohrn, who were Boudin's comrades in the communist terrorist group, after Kathy Boudin went to prison for her involvement in an armed robbery and assault that took the...

This release is available in French.Quebec City, October 27, 2010—High doses or prolonged use of glucosamine causes the death of pancreatic cells and could increase the risk of developing diabetes, according to a team of researchers at Université Laval's Faculty of Pharmacy. Details of this discovery were recently published on the website of the Journal of Endocrinology. In vitro tests conducted by Professor Frédéric Picard and his team revealed that glucosamine exposure causes a significant increase in mortality in insulin-producing pancreatic cells, a phenomenon tied to the development of diabetes. Cell death rate increases with glucosamine dose and exposure time....

Merck (MRK), the world's second largest drugmaker, said Thursday it plans to close eight manufacturing plants and eight research facilities around the world in its bid to save $3.5 billion a year. The Whitehouse Station, N.J.-based company is also reducing its workforce by 15%, or some 16,000 jobs, it said. The actions are part of a restructuring the company has undertaken following its $41 billion acquisition of rival Schering-Plough in November. In addition to the plant closings, Merck said it will consolidate some offices worldwide, as part of the restructuring begun last December. "Today's announcement is another important step as...

A gene silencing approach can save monkeys from high doses of the most lethal strain of Ebola virus in what researchers call the most viable route yet to treating the deadly and frightening infection. They used small interfering RNAs or siRNAs, a new technology being developed by a number of companies, to hold the virus at bay for a week until the immune system could take over. Tests in four rhesus monkeys showed that seven daily injections cured 100 per cent of them. U.S. government researchers and a small Canadian biotech company, Tekmira Pharmaceuticals, worked together to develop the new...

Pfizer, the largest drug maker in the world, disclosed 35 million in payments during the second half of 2009 to doctors who consulted or spoke on behalf of drugs and to the medical centers that tested them, The New York Times reports. This is Pfizer's first disclosure of this nature. "While other pharmaceutical companies have disclosed payments to doctors, Pfizer is the first to disclose payments for the clinical trials. The disclosure does not include payments outside the United States" (Wilson, 3/31). "The drugmaker made the disclosure as part of a government settlement after it pleaded guilty last year to...

Dr. Arthur Laffer, one of the great economic minds of our generation recently published a piece whose title he adapted from a quote by Steven Landsburg: "Economics Can Be Summarized In Four Words: People Respond to Incentives." Companies are just like people. In the early 1990's when BillaryCare was on the table, the Clinton Administration decided they needed a villain (sound familiar?) so they began a vicious attack on the pharmaceutical industry. The only problem was, the pharmaceutical companies were busy developing drugs like Lipitor that prevent costly and serious health problems such as strokes and heart disease. BillaryCare failed...

Enfield, Conn. (WTNH) - Thieves broke into an Enfield warehouse filled with prescription drugs over the weekend, getting away with up to $75 million worth of narcotics. The large, non-descript brown building back in the woods in Enfield is a transportation hub of sorts for prescription drug company Eli Lilly . Over the weekend someone cut a hole in the roof and rappelled inside, stealing between $50-$75 million worth of drugs. It's the largest theft in town history. "The hole was very high up and there was no way they you would be able to leap to the floor," Enfield...

The Obama Administration plan to put new generic drugs on the street faster is another example of how Washington healthcare reformers just don’t get it. While it is true that more generic drugs will reduce healthcare costs, it also is true that health risks will increases for many individuals sensitive to even the slightest changes in their medications. The Obama drug plan imposes $10 billion in fees over ten years on the brand-name pharmaceutical industry, to be parceled out among big drug makers to eliminate the so-called donut hole, or gap, in Medicare prescription drug coverage. The idea is to...

... Mr. Tauzin, 66, will retreat, to contemplate the apparent collapse of the grandest in a career of fearless deals — a pact to trade the drug industry’s political support for favorable terms under President Obama’s proposed health care overhaul. Mr. Tauzin is leaving his $2 million-a-year job as the top lobbyist for the drug industry amid complaints from drug makers that he bargained away their profits too cheaply, spent too much in his $150 million advertising campaign to sell the overhaul and miscalculated in his assessment that the passage of the legislation was all but inevitable. Other drug industry...

BRITAIN’s biggest drugs company, Glaxo Smith Kline, is to axe up to 4,000 more jobs as part of its plans to restructure its workforce and focus increasingly on emerging markets. The bulk of the cuts will be in America and Europe, and are part of the company’s efforts to shift resources away from low-growth territories into parts of the world with greater scope to expand sales. Glaxo, which has been headed for nearly two years by chief executive Andrew Witty, employs 99,000 staff across the world and is expected to reveal plans for select cutbacks alongside its annual results this...

The drug industry is threatening to end its support for President Barack Obama's health overhaul effort because of a rift with the administration over protecting brand-name biotech drugs from low-cost generic competitors. In an e-mail obtained Friday by The Associated Press, the president of the Pharmaceutical Research and Manufacturers of America told the trade group's board members that "we could not support the bill" if the industry is given less than 12 years of competitive protection for the expensive products. Obama and House Energy and Commerce Committee Chairman Henry Waxman, D-Calif., are leading the drive to shorten that period, which...

WASHINGTON -- The drug industry is threatening to end its support for President Barack Obama's health overhaul effort because of a rift with the administration over protecting brand-name biotech drugs from low-cost generic competitors. In an e-mail obtained Friday by The Associated Press, the president of the Pharmaceutical Research and Manufacturers of America told the trade group's board members that "we could not support the bill" if the industry is given less than 12 years of competitive protection for the expensive products. Obama and House Energy and Commerce Committee Chairman Henry Waxman, D-Calif., are leading the drive to shorten that...

Following the MA Senate debate on Monday, Martha Coakley was off to Washington DC where a big fundraiser was being held for her. Per the Washington Examiner, "17 of the 22 names on the host committee are federally registered lobbyists. Fifteen of those 17 have big health care clients such as Pfizer, Merck, Amgen, Sanofi-Aventis, Eli Lilly, Novartis, Astra-Zeneca, Blue Cross/Blue Shield, Cigna, Humana, HealthSouth, and United Health among many others. In addition, among the other five hosts there are direction connections via marriage and/or direct professional ties to the health care industry." After the fundraising event, Coakley took two...

How Angry is the Left at Obama? Watch this Video

The pharmaceutical industry's powerful Washington lobbying group backs the healthcare reform legislation that is President Barack Obama's top legislative priority, but its important support for that effort could evaporate if drug imports are included. White House adviser David Axelrod said the administration will pursue the issue, but not in the healthcare reform bill. "Let me be clear. The president supports ... safe re-importation of drugs into this country," Axelrod told CNN's "State of the Union" program. "There's no reason why Americans should pay a premium for the pharmaceuticals that people in other countries pay less for." The importation of drugs...

One more item added to what candidate Obama said on the campaign trail about prescription drugs (see bolded paragraph) and what President Obama who cut a deal with drug companies has to say. No wonder Obama's poll numbers are falling so rapidly as he continues to do a 180 from what he said on the campaign trail. When we first heard about Obama's ties to radicals like Communist Frank Davis who was his mentor, Bill Ayers, Bernadine Dohrn, Louis Farrakhan, and others we suspected he would lurch to the left if he was elected. That said, his lurch to the...